Relevance of High-Mobility Group Protein Box 1 to Neurodegeneration

International Review of Neurobiology

Volumn 82, Issue , 2007, Pages 137-148

  Fossati, Silvia ^a   Chiarugi, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN;

ANIMAL; CELL NUCLEUS; CENTRAL NERVOUS SYSTEM DISEASE; CHEMISTRY; DEGENERATIVE DISEASE; HUMAN; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CELL NUCLEUS; CENTRAL NERVOUS SYSTEM DISEASES; CYTOKINES; HMGB1 PROTEIN; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 34547346782     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(07)82007-1     Document Type: Review

References (40)

1. Agnello D., Wang H., Yang H., Tracey K.J., and Ghezzi P. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 18 (2002) 231-236
2. Allain F.H., Yen Y.M., Masse J.E., Schultze P., Dieckmann T., Johnson R.C., and Feigon J. Solution structure of the HMG protein NHP6A and its interaction with DNA reveals the structural determinants for non-sequence-specific binding. EMBO J. 18 (1999) 2563-2579
3. Bell C.W., Jiang W., Reich III C.F., and Pisetsky D.S. The extracellular release of HMGB1 during apoptotic cell death. Am. J. Physiol. Cell Physiol. 291 (2006) C1318-C1325
4. Bianchi M.E. Interview with Dr. Heikki Rauvala regarding pivotal advance: Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J. Leukoc. Biol. 81 (2007) 1-5
5. Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., Rubartelli A., Agresti A., and Bianchi M.E. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22 (2003) 5551-5560
6. Calogero S., Grassi F., Aguzzi A., Voigtlander T., Ferrier P., Ferrari S., and Bianchi M.E. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat. Genet. 22 (1999) 276-280
7. Chou D.K., Zhang J., Smith F.I., McCaffery P., and Jungalwala F.B. Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration. J. Neurochem. 90 (2004) 1389-1401
8. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci. 22 (1999) 391-397
9. Ellwood K.B., Yen Y.M., Johnson R.C., and Carey M. Mechanism for specificity by HMG-1 in enhanceosome assembly. Mol. Cell. Biol. 20 (2000) 4359-4370
10. Giese K., Amsterdam A., and Grosschedl R. DNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1. Genes Dev. 5 (1991) 2567-2578
11. Goldstein R.S., Gallowitsch-Puerta M., Yang L., Rosas-Ballina M., Huston J.M., Czura C.J., Lee D.C., Ward M.F., Bruchfeld A.N., Wang H., Lesser M.L., Church A.L., et al. Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 25 (2006) 571-574
12. Goodwin G.H., and Johns E.W. Isolation and characterisation of two calf-thymus chromatin non-histone proteins with high contents of acidic and basic amino acids. Eur. J. Biochem. 40 (1973) 215-219
13. Guazzi S., Strangio A., Franzi A.T., and Bianchi M.E. HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain. Gene Expr. Patterns 3 (2003) 29-33
14. Hoppe G., Talcott K.E., Bhattacharya S.K., Crabb J.W., and Sears J.E. Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp. Cell Res. 312 (2006) 3526-3538
15. Killeen M.E., Englert J.A., Stolz D.B., Song M., Han Y., Delude R.L., Kellum J.A., and Fink M.P. The phase 2 enzyme inducers ethacrynic acid, DL-sulforaphane, and oltipraz inhibit lipopolysaccharide-induced high-mobility group box 1 secretion by RAW 264.7 cells. J. Pharmacol. Exp. Ther. 316 (2006) 1070-1079
16. Kim J.B., Sig C.J., Yu Y.M., Nam K., Piao C.S., Kim S.W., Lee M.H., Han P.L., Park J.S., and Lee J.K. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J. Neurosci. 26 (2006) 6413-6421
17. Landsman D., and Bustin M. A signature for the HMG-1 box DNA-binding proteins. Bioessays 15 (1993) 539-546
18. Limana F., Germani A., Zacheo A., Kajstura J., Di Carlo A., Borsellino G., Leoni O., Palumbo R., Battistini L., Rastaldo R., Muller S., Pompilio G., et al. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ. Res. 97 (2005) e73-e83
19. Lo E.H., Dalkara T., and Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4 (2003) 399-415
20. Lotze M.T., and Tracey K.J. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5 (2005) 331-342
21. McKinney K., and Prives C. Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein. Mol. Cell. Biol. 22 (2002) 6797-6808
22. Merenmies J., Pihlaskari R., Laitinen J., Wartiovaara J., and Rauvala H. 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J. Biol. Chem. 266 (1991) 16722-16729
23. O'Connor K.A., Hansen M.K., Rachal P.C., Deak M.M., Biedenkapp J.C., Milligan E.D., Johnson J.D., Wang H., Maier S.F., Tracey K.J., and Watkins L.R. Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: Central nervous system effects. Cytokine 24 (2003) 254-265
24. Park J.S., Arcaroli J., Yum H.K., Yang H., Wang H., Yang K.Y., Choe K.H., Strassheim D., Pitts T.M., Tracey K.J., and Abraham E. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 284 (2003) C870-C879
25. Park J.S., Svetkauskaite D., He Q., Kim J.Y., Strassheim D., Ishizaka A., and Abraham E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279 (2004) 7370-7377
26. Passalacqua M., Patrone M., Picotti G.B., Del Rio M., Sparatore B., Melloni E., and Pontremoli S. Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation. Neuroscience 82 (1998) 1021-1028
27. Pedrazzi M., Raiteri L., Bonanno G., Patrone M., Ledda S., Passalacqua M., Milanese M., Melloni E., Raiteri M., Pontremoli S., and Sparatore B. Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein. J. Neurochem. 99 (2006) 827-838
28. Rauvala H., and Pihlaskari R. Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons. J. Biol. Chem. 262 (1987) 16625-16635
29. Sakamoto R., Okano M., Takena H., and Ohtsuki K. Inhibitory effect of glycyrrhizin on the phosphorylation and DNA-binding abilities of high mobility group proteins 1 and 2 in vitro. Biol. Pharm. Bull. 24 (2001) 906-911
30. Scaffidi P., Misteli T., and Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418 (2002) 191-195
31. Takata K., Kitamura Y., Kakimura J., Shibagaki K., Tsuchiya D., Taniguchi T., Smith M.A., Perry G., and Shimohama S. Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis. Biochem. Biophys. Res. Commun. 301 (2003) 699-703
32. Takata K., Kitamura Y., Tsuchiya D., Kawasaki T., Taniguchi T., and Shimohama S. High mobility group box protein-1 inhibits microglial Abeta clearance and enhances Abeta neurotoxicity. J. Neurosci. Res. 78 (2004) 880-891
33. Ulloa L., and Messmer D. High-mobility group box 1 (HMGB1) protein: Friend and foe. Cytokine Growth Factor Rev. 17 (2006) 189-201
34. Ulloa L., Ochani M., Yang H., Tanovic M., Halperin D., Yang R., Czura C.J., Fink M.P., and Tracey K.J. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl. Acad. Sci. USA 99 (2002) 12351-12356
35. Verrijdt G., Haelens A., Schoenmakers E., Rombauts W., and Claessens F. Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors. Biochem. J. 361 (2002) 97-103
36. Wang H., Vishnubhakat J.M., Bloom O., Zhang M., Ombrellino M., Sama A., and Tracey K.J. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126 (1999) 389-392
37. Yang D., Chen Q., Yang H., Tracey K.J., Bustin M., and Oppenheim J.J. High mobility group box-1 (HMGB1) protein induces the migration and activation of human dendritic cells and acts as an alarmin. J. Leukoc. Biol. 81 (2007) 59-66
38. Yang H., Ochani M., Li J., Qiang X., Tanovic M., Harris H.E., Susarla S.M., Ulloa L., Wang H., DiRaimo R., Czura C.J., Wang H., et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. USA 101 (2004) 296-301
39. Yu M., Wang H., Ding A., Golenbock D.T., Latz E., Czura C.J., Fenton M.J., Tracey K.J., and Yang H. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26 (2006) 174-179
40. Yu S.S., Li H.J., Goodwin G.H., and Johns E.W. Interaction of non-histone chromosomal proteins HMG1 and HMG2 with DNA. Eur. J. Biochem. 78 (1977) 497-502